BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program

Go back to BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
(AMEX: BMKDF) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High $0.14 
Open $0.38    52 Week Low $0.04 
Day High $0.38    P/E N/A 
Day Low $0.38    EPS $0.00 
Volume 64,517